IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanage, W. P.
Right arrow Articles by Spratt, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanage, W. P.
Right arrow Articles by Spratt, B. G.

 Previous Article  |  Next Article 

Infection and Immunity, January 2004, p. 76-81, Vol. 72, No. 1
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.1.76-81.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Ability of Pneumococcal Serotypes and Clones To Cause Acute Otitis Media: Implications for the Prevention of Otitis Media by Conjugate Vaccines

William P. Hanage,1 Kari Auranen,2 Ritva Syrjänen,2 Elja Herva,3 P. Helena Mäkelä,2 Terhi Kilpi,2 and Brian G. Spratt1*

Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, St. Mary's Hospital, London W2 1PG, United Kingdom,1 Department of Vaccines, National Public Health Institute, 00100 Helsinki,2 Department of Microbiology, National Public Health Institute, 90101 Oulu, Finland3

Received 11 June 2003/ Returned for modification 23 July 2003/ Accepted 24 September 2003

The relative abilities of pneumococcal serotypes and strains (clones) to cause acute otitis media (AOM) were investigated by comparing the serotypes and genotypes of pneumococci recovered from cases of AOM (n = 149) in children <2 years of age with those from nasopharyngeal carriage (n = 288) in age-matched controls from the same region. The odds ratio (OR) for association of pooled vaccine serotypes with AOM was found to be slightly elevated over unity, although this was not significantly different from that of pooled nonvaccine or vaccine-related serotypes. Comparing individual serotypes, 19F and 23F had 2- to 2.5-fold higher ORs, although these were not markedly different from the ORs of nonvaccine serotypes. None of the major clones had an OR that was significantly greater than the average, and the differences in ORs among serotypes and clones were much less than those for invasive disease, suggesting little variation in their ability to cause AOM. We conclude that serotype replacement may reduce the long-term efficacy of these vaccines against AOM.


* Corresponding author. Mailing address: Department of Infectious Disease Epidemiology, Old Medical School Building, St. Mary's Hospital, Imperial College London, London W2 1PG, United Kingdom. Phone: 44 20 7594 3629. Fax: 44 20 7594 3693. E-mail: b.spratt{at}imperial.ac.uk.

Editor: J. N. Weiser


Infection and Immunity, January 2004, p. 76-81, Vol. 72, No. 1
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.1.76-81.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2004 by the American Society for Microbiology. All rights reserved.